Literature DB >> 31214169

Corrigendum: Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies.

Cristina Cifaldi1, Immacolata Brigida2, Federica Barzaghi2,3,4, Matteo Zoccolillo2,4, Valentina Ferradini5, Davide Petricone4, Maria Pia Cicalese2,3,6, Dejan Lazarevic7, Davide Cittaro7, Maryam Omrani2, Enrico Attardi1, Francesca Conti1, Alessia Scarselli1, Maria Chiriaco1, Silvia Di Cesare1, Francesco Licciardi8, Montin Davide8, Francesca Ferrua2,3,6, Clementina Canessa9,10, Claudio Pignata11, Silvia Giliani12, Simona Ferrari13, Georgia Fousteri14, Graziano Barera15, Pietro Merli16, Paolo Palma1, Simone Cesaro17, Marco Gattorno18, Antonio Trizzino19, Viviana Moschese4,20, Loredana Chini4,20, Anna Villa21,22, Chiara Azzari9,10, Andrea Finocchi1,4, Franco Locatelli23, Paolo Rossi1,4, Federica Sangiuolo5, Alessandro Aiuti2,3,6, Caterina Cancrini1,4, Gigliola Di Matteo1,4.   

Abstract

[This corrects the article DOI: 10.3389/fimmu.2019.00316.].

Entities:  

Keywords:  Haloplex; Ion Torrent; Next Generation Sequencing; gene panels; primary immunodeficiencies

Year:  2019        PMID： 31214169      PMCID： PMC6554535          DOI： 10.3389/fimmu.2019.01184

Source DB:  PubMed          Journal:  Front Immunol        ISSN： 1664-3224            Impact factor:   7.561


In the published article, there was an error in affiliation “18.” Instead of “Pediatric and Rheumatology Unit, Giannina Gaslini Institute, Genoa, Italy,” it should be “Center for Autoinflammatory Diseases and Immunodeficiencies, IRCCS Giannina Gaslini, Genoa, Italy.” The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
  2 in total

1.  Efficacy and economics of targeted panel versus whole-exome sequencing in 878 patients with suspected primary immunodeficiency.

Authors:  Craig D Platt; Fatima Zaman; Wayne Bainter; Kelsey Stafstrom; Abuarahman Almutairi; Margot Reigle; Sabrina Weeks; Raif S Geha; Janet Chou
Journal:  J Allergy Clin Immunol       Date:  2020-09-02       Impact factor: 10.793

2.  Targeted NGS Yields Plentiful Ultra-Rare Variants in Inborn Errors of Immunity Patients.

Authors:  Alice Grossi; Maurizio Miano; Marina Lanciotti; Francesca Fioredda; Daniela Guardo; Elena Palmisani; Paola Terranova; Giuseppe Santamaria; Francesco Caroli; Roberta Caorsi; Stefano Volpi; Marco Gattorno; Carlo Dufour; Isabella Ceccherini
Journal:  Genes (Basel)       Date:  2021-08-24       Impact factor: 4.096
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.